The domestic COVID-19 vaccine debut for the first time!

In the context of the global COVID-19 pandemic, the development of vaccines has attracted much attention.

The China International Trade in Services Fair 2020 will be held in Beijing from September 5 to 9.

Developed from China Biology, the CNBG group developed two new COVID-19 inactivated vaccines, its debut attracting worldwide attention.

photo credit: CNBG

Among them, the specific immunoglobulin, known as the "golden key" for the treatment of critically ill patients, played an important role in the prevention and control of the epidemic in Hubei province, and in the treatment of critically ill patients in the outbreak of the epidemic in Xinfang, Beijing and Urumqi, Xinjiang.

Specific immunoglobulin

At present, China's two new biological crown Ⅲ of inactivated vaccines have been in the final phase of the clinical trial stage in United Arab emirates, Bahrain, Peru, Morocco, Argentina and other countries and regions.

Fifty thousand people were enrolled and the sample population covered 115 countries, leading the world in all aspects.

Covid-19 inactivated vaccine

At the same time, China Biological is building high-grade biosafety production facilities in Beijing and Wuhan, two biological products research institutes, with a combined annual capacity of 300 million doses.

Hope the epidemic will end soon and everyone will lead a normal life.

Source: CNBG

Editor: Crystal H

Editor's Pick